ACM
Altium Capital Management’s ADMA Biologics ADMA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,395,000
| Closed | -$23.9M | – | 23 |
|
|
2024
Q4 | $23.9M | Buy |
1,395,000
+35,000
| +3% | +$600K | 6.79% | 1 |
|
|
2024
Q3 | $27.2M | Sell |
1,360,000
-150,000
| -10% | -$3M | 8% | 2 |
|
|
2024
Q2 | $16.9M | Sell |
1,510,000
-30,000
| -2% | -$335K | 6.89% | 2 |
|
|
2024
Q1 | $10.2M | Buy |
1,540,000
+445,000
| +41% | +$2.94M | 4.02% | 4 |
|
|
2023
Q4 | $4.95M | Sell |
1,095,000
-1,628,011
| -60% | -$7.36M | 3.36% | 13 |
|
|
2023
Q3 | $9.75M | Buy |
2,723,011
+343,011
| +14% | +$1.23M | 5.08% | 6 |
|
|
2023
Q2 | $8.78M | Sell |
2,380,000
-490,000
| -17% | -$1.81M | 6.65% | 4 |
|
|
2023
Q1 | $9.5M | Hold |
2,870,000
| – | – | 5.27% | 2 |
|
|
2022
Q4 | $11.1M | Sell |
2,870,000
-13,710
| -0.5% | -$53.2K | 5.66% | 2 |
|
|
2022
Q3 | $7.01M | Sell |
2,883,710
-1,116,290
| -28% | -$2.71M | 2.57% | 5 |
|
|
2022
Q2 | $7.92M | Buy |
4,000,000
+700,000
| +21% | +$1.39M | 3.17% | 3 |
|
|
2022
Q1 | $6.04M | Hold |
3,300,000
| – | – | 2.02% | 10 |
|
|
2021
Q4 | $4.65M | Buy |
+3,300,000
| New | +$4.65M | 1.28% | 27 |
|